An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Madrigal expresses deep sorrow over the passing of Dr. Stephen Harrison, a pivotal figure in NASH research. Dr. Harrison's dedication to improving the lives of NASH patients and his collaborative approach with various stakeholders leaves a lasting impact on the field of hepatology.
Madrigal esprime profondo dolore per la scomparsa del Dr. Stephen Harrison, una figura chiave nella ricerca sulla NASH. L'impegno del Dr. Harrison nel migliorare la vita dei pazienti affetti da NASH e il suo approccio collaborativo con vari stakeholder hanno lasciato un impatto duraturo nel campo dell'epatologia.
Madrigal expresa un profundo pesar por el fallecimiento del Dr. Stephen Harrison, una figura clave en la investigación de NASH. La dedicación del Dr. Harrison para mejorar las vidas de los pacientes con NASH y su enfoque colaborativo con diferentes partes interesadas han dejado un impacto perdurable en el campo de la hepatología.
매드리갈은 NASH 연구에서 중추적인 인물인 스티븐 해리슨 박사의 별세에 깊은 슬픔을 표합니다. 해리슨 박사의 NASH 환자의 삶을 개선하기 위한 헌신과 다양한 이해 관계자들과의 협력적 접근은 간학 분야에 지속적인 영향을 미쳤습니다.
Madrigal exprime une profonde tristesse suite au décès du Dr. Stephen Harrison, figure emblématique de la recherche sur la NASH. Le dévouement du Dr. Harrison à améliorer la vie des patients atteints de NASH et son approche collaborative avec diverses parties prenantes laissent un impact durable dans le domaine de l’hépatologie.
Madrigal drückt tiefe Trauer über den Tod von Dr. Stephen Harrison aus, einer Schlüsselfigur in der NASH-Forschung. Dr. Harrisons Engagement zur Verbesserung des Lebens von NASH-Patienten und sein kooperativer Ansatz mit verschiedenen Stakeholdern hinterlassen einen bleibenden Einfluss im Bereich der Hepatologie.
Positive
None.
Negative
None.
CONSHOHOCKEN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- The Madrigal team is shocked and saddened to learn of the passing of Dr. Stephen Harrison.
We offer our deepest condolences to Stephen’s family for their loss.
Stephen was a colleague and friend to so many of us at Madrigal. He worked tirelessly to improve the lives of people with nonalcoholic steatohepatitis (NASH), and his contributions to the field will touch countless families across the globe for decades to come. So many of the recent innovations and achievements we’ve seen in NASH research stemmed from his constant collaboration with partners in academia, industry, the regulatory sciences, and the patient community.
Stephen was much more than a brilliant investigator and physician; he was a true leader who inspired all of us with his commitment to patients. We’ll remember his sense of humor, his courtesy, and his boundless energy and optimism.
The field of hepatology has lost a true giant.
FAQ
Who passed away according to the Madrigal statement?
Dr. Stephen Harrison passed away as mentioned in the Madrigal statement.
What was Dr. Stephen Harrison's contribution to the field of NASH?
Dr. Stephen Harrison worked tirelessly to improve the lives of people with nonalcoholic steatohepatitis (NASH) and collaborated with partners in academia, industry, regulatory sciences, and the patient community, leading to significant innovations and achievements in NASH research.
How is Dr. Stephen Harrison described in the Madrigal statement?
Dr. Stephen Harrison is described as a brilliant investigator, physician, and true leader who inspired others with his commitment to patients, sense of humor, courtesy, boundless energy, and optimism.
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.
